ENvue Medical
(NASDAQ) NAOV
ENvue Medical Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$2.69M
Net Income (TTM)
$3.57M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
NAOV News
NAOV: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout ENvue Medical
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
31
CEO
Doron Robert Besser, MD
Website
www.nanovibronix.comHeadquarters
Elmsford, NY 10523, US
NAOV Financials
Key Financial Metrics (TTM)
Gross Margin
30%
Operating Margin
-4%
Net Income Margin
-1%
Return on Equity
-12%
Return on Capital
-22%
Return on Assets
-6%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$1.51M
Operating Income
$3.58M
EBITDA
$3.69M
Operating Cash Flow
$2.52M
Capital Expenditure
$3.00K
Free Cash Flow
$2.52M
Cash & ST Invst.
$752.00K
Total Debt
$116.00K
ENvue Medical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$722.00K
+92.0%
Gross Profit
$189.00K
+42.1%
Gross Margin
26.18%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
31
N/A
Net Income
$510.00K
+151.1%
EBITDA
$855.00K
+188.9%
Quarterly Fundamentals
Net Cash
$3.78M
+220.6%
Accounts Receivable
$252.00K
-69.3%
Inventory
$2.24M
-0.3%
Long Term Debt
$15.00K
-80.5%
Short Term Debt
$3.15M
+6338.8%
Return on Assets
-6.40%
N/A
Return on Invested Capital
-22.10%
N/A
Free Cash Flow
$2.00M
-139.0%
Operating Cash Flow
$1.97M
-135.6%